✦ LIBER ✦

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer

✍ Scribed by Sil Kordes, Dick J. Richel, Heinz-Josef Klümpen, Mariëtte J. Weterman, Arnoldus J. W. M. Stevens, Johanna W. Wilmink

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Study of Cetuximab in Combinat

✍ A.B. Chakravarthy; J.D. Berlin; A.C. Lockhart; E. Chan; A. Parikh; V. Kordowski; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A phase II study of capecitabine and doc

✍ Park, Y H; Ryoo, B-Y; Choi, S-J; Kim, H-T 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

A phase II study of cetuximab, capecitab

✍ V. Velenik; J. Ocvirk; I. Oblak; F. Anderluh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 355 KB

A phase I and pharmacokinetic study of c

✍ Roxburgh, Patricia; Lumsden, Graeme R.; Paul, James; Harden, Sharon; Sweeting, L 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 299 KB

646 POSTER Phase I/II study of preoperat

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Randomized phase II – study evaluating E

✍ R Krempien; MW Muenter; PE Huber; S Nill; H Friess; C Timke; B Didinger; P Buech 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 321 KB